- Home
- BCBP vs CRVS Comparison
BCBP vs CRVS Comparison
Compare BCBP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- CRVS
- Stock Information
- Founded
- BCBP 2000
- CRVS 2014
- Country
- BCBP United States
- CRVS United States
- Employees
- BCBP N/A
- CRVS N/A
- Industry
- BCBP Savings Institutions
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- CRVS Health Care
- Exchange
- BCBP Nasdaq
- CRVS Nasdaq
- Market Cap
- BCBP 136.5M
- CRVS 459.0M
- IPO Year
- BCBP N/A
- CRVS 2016
- Fundamental
- Price
- BCBP $8.21
- CRVS $7.32
- Analyst Decision
- BCBP Hold
- CRVS Strong Buy
- Analyst Count
- BCBP 2
- CRVS 4
- Target Price
- BCBP $9.50
- CRVS $13.75
- AVG Volume (30 Days)
- BCBP 66.8K
- CRVS 1.0M
- Earning Date
- BCBP 10-17-2025
- CRVS 11-11-2025
- Dividend Yield
- BCBP 7.80%
- CRVS N/A
- EPS Growth
- BCBP N/A
- CRVS N/A
- EPS
- BCBP 0.19
- CRVS N/A
- Revenue
- BCBP $65,498,000.00
- CRVS N/A
- Revenue This Year
- BCBP $23.31
- CRVS N/A
- Revenue Next Year
- BCBP $6.72
- CRVS N/A
- P/E Ratio
- BCBP $42.97
- CRVS N/A
- Revenue Growth
- BCBP N/A
- CRVS N/A
- 52 Week Low
- BCBP $7.54
- CRVS $2.54
- 52 Week High
- BCBP $14.04
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- BCBP 47.19
- CRVS 59.79
- Support Level
- BCBP $7.87
- CRVS $6.81
- Resistance Level
- BCBP $8.16
- CRVS $7.98
- Average True Range (ATR)
- BCBP 0.20
- CRVS 0.54
- MACD
- BCBP 0.00
- CRVS -0.05
- Stochastic Oscillator
- BCBP 55.82
- CRVS 72.33
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).